Reduction of cardiovascular risk factors among young men with hypertension using an interactive decision aid:

Liina Kask-Flight1, Koray Durak2, Kadri Suija3

  • 1Institute of Family Medicine and Public Health, Faculty of Medicine, University of Tartu, Tartu, Estonia. liina.kaskflight@tlpak.ee.

Insights

Interactive decision aids (DA) in family practice significantly reduced cardiovascular risk factors in young men. This computer-based tool proved more effective than usual counseling for smoking cessation and blood pressure reduction.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Health Informatics

Background:

  • High coronary heart disease (CHD) mortality in young men necessitates effective prevention strategies.
  • Limited prevention methods are available for family practice (FP) settings.
  • Investigating cardiovascular risk profiles in young males (18-50) visiting family doctors (FDs) is crucial.

Purpose of the Study:

  • To assess the cardiovascular risk profile of young males (18-50) in a family doctor setting.
  • To determine if an interactive computer-based decision aid (DA) improves cardiovascular risk factor reduction compared to usual counseling.

Main Methods:

  • A cluster-randomized controlled trial involving hypertensive male patients aged 18-50.
  • Family doctors (FDs) were randomized into intervention (using DA) and control (usual counseling) groups.
  • Data collected via questionnaires, clinical exams, and lab analyses at baseline and 3-month follow-up.

Main Results:

  • The decision aid (DA) group showed significantly greater smoking reduction compared to the control group.
  • Patients using the DA experienced statistically significant reductions in systolic blood pressure (SBP), diastolic blood pressure (DBP), and daily cigarette consumption.
  • Hypertension grade 2 patients using the DA had a significantly greater SBP reduction than grade 1 patients.

Conclusions:

  • Interactive decision aids (DAs) in family practice can enhance patient understanding of risk factors and treatment choices.
  • DAs are more effective than standard counseling for promoting behavioral changes, such as smoking cessation and blood pressure reduction, in young hypertensive men.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
120
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
896
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
159
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
159